Retraction: Corrigendum: ErHuang formula improves renal fibrosis in diabetic nephropathy rats by inhibiting CXCL6/JAK/STAT3 signaling pathway
Saved in:
| Main Author: | Frontiers Editorial Office |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Pharmacology |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1530384/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Retraction: ErHuang formula improves renal fibrosis in diabetic nephropathy rats by inhibiting CXCL6/JAK/STAT3 signaling pathway
by: Frontiers Editorial Office
Published: (2024-12-01) -
RETRACTED: Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway
by: Yu-Li Shen, et al.
Published: (2021-11-01) -
Retraction: Mendelian randomization based on immune cells in diabetic nephropathy
by: Frontiers Editorial Office
Published: (2025-02-01) -
Retraction: Lycorine displays potent antitumor efficacy in colon carcinoma by targeting STAT3
by: Frontiers Editorial Office
Published: (2025-03-01) -
WCN24-186 JAK/STAT EXPRESSION IN PATIENTS WITH IGA NEPHROPATHY
by: Mateus Luvizotto, et al.
Published: (2024-04-01)